Results 191 to 199 of about 786,579 (199)

Anti-PD-1/PD-L1 Immunotherapy as a Potential Treatment Option for Lung Cancer: A Perspective Analysis of Opportunities and Challenges. [PDF]

Health Sci Rep
Mohiuddin M.
europepmc   +1 more source

Metastatic organ count stratifies survival in immunotherapy-treated metastatic colorectal cancer: a retrospective cohort study. [PDF]

Front Immunol
Fu HY, Zhang YY, Wang Y, Huang JS, Tian JH, Wang N, Bai KH, Wang ZQ.   +7 more
europepmc   +1 more source

Capturing durable benefits: interpreting six-year treatment-free survival and restricted mean survival time in CheckMate 227. [PDF]

J Thorac Dis
Kobayashi T, Nakamura S, Hakozaki T.
europepmc   +1 more source

Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma

David R. Glass, Koshlan Mayer-Blackwell, Nirasha Ramchurren, K. Rachael Parks, George E. Durán, Anna K. Wright, Armando N Bastidas Torres, Laura Islas, Youn H. Kim, Steven P. Fling, Michael S. Khodadoust, Evan W. Newell   +11 more
openalex   +1 more source

Tracking temporal shifts of peripheral blood NLR, PLR, and ALB: a prognostic tool for PD-1 inhibitor efficacy in advanced malignant melanoma. [PDF]

Front Oncol
Deng Y, Han Y, Meng X, Pei J, Yang M, Xiao Z, Wang F, Lu T.   +7 more
europepmc   +1 more source

DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy. [PDF]

Int J Gen Med
Kumari K, Kumar V, Verma C, Hsu PC, Singh A.   +4 more
europepmc   +1 more source

Magnesium and Cancer Immunotherapy: A Narrative Practical Review. [PDF]

Nutrients
Sambataro D, Scandurra G, Gebbia V, Greco M, Ciminna A, Valerio MR.   +5 more
europepmc   +1 more source